GENinCode plc
Company Profile
Company website
Sector
Medical Equipment and Services (Medical Services)
Description
GENinCode plc (AIM: GENI) is engaged in the risk assessment, prediction and prevention of cardiovascular disease (“CVD”). CVD is the leading cause of death worldwide accounting for approximately 18 million deaths annually.
Investor Access
02
Oct
Event information
Matthew Walls, Chief Executive Officer, and Paul Foulger, Chief Financial Officer, will provide a live presentation relating to the results via the Investor Meet Company platform on Thursday, 2 October 2025 at 11.00am BST.
Investors can sign up to Investor Meet Company for free and add to meet GENinCode here.
Venue
Online
Time
Thursday, 2 October 2025 at 11.00am BST.
Financial Calendar
| Event | Date |
| Year End | December 31 |
| Half Year End | 30 June |
| Preliminary Results* | March/April |
| Interim Results* | September |
| AGM* | June |
* Months based on previous announcements of this kind
